Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa
This is a good example of the potential of genome-wide association studies to transform the understanding of an illness — especially one without good treatments.
From the conclusion:
Low BMI has traditionally been viewed as a consequence of the psychological features of anorexia nervosa (that is, drive for thinness and body dissatisfaction). This perspective has failed to yield interventions that reliably lead to sustained weight gain and psychological recovery7. Fundamental metabolic dysregulation may contribute to the exceptional difficulty that individuals with anorexia nervosa have in maintaining a healthy BMI (even after therapeutic renourishment). Our results encourage consideration of both metabolic and psychological drivers of anorexia nervosa when exploring new avenues for treating this frequently lethal illness.
Abstract:
These results further encourage a reconceptualization of anorexia nervosa as a metabo-psychiatric disorder. Elucidating the metabolic component is a critical direction for future research, and paying attention to both psychiatric and metabolic components may be key to improving outcomes.
Brief commentary on the study
The study expands on a 2017 study with 3,500 cases. The new study pulled in a lot of other anorexia nervosa GWAS to give almost 17,000 cases and 55,000 controls. Given that anorexia nervosa is highly heritable (50 to 60%, according to twin studies), where genetic defects will be bigger, that's a big sample.
There isn't reliable data on ME/CFS heritability, but the estimates that exist put it at around 20%.
The study identified eight different risk loci (chromosomal locations), each with multiple hits.
As with all GWAS, the significant SNPs are effectively markers, flagging up sections of DNA that increase or decrease disease risk. However, because DNA sequences that are close together tend to be inherited together, GWAS aloe can't be precise in identifying exactly which genes are involved.
The authors wnet on to use a range of techniques to identify the genes most likely to be causally involved, identifying 133 candidate genes. A handful of genes looked to be particularly strong candidates.
Instead, the main way the study tried to identify what underlying genes are involved was to see which of the SNPs that were significant in this GWAS were also significant in GWAS for other diseases and traits.
First they found that SNPs that were risk factors for AN are also risk factors for psychological illnesses including obsessive-compulsive disorder (most strongly), anxiety and schizophrenia. They noted that these genetic patterns reflected comorbidities seeing in clinical and epidemiological studies.
The authors also found that quite a few of the anorexia nervosa SNPs predicted "good" metabolic outcomes, protecting against insulin resistance and type II diabetes, for instance.
Similarly, anorexia nervosa SNPs also predit low body fat percentage, low-fat mass, small waist conference, low BMI and reduced risk of obesity.
Note that genetic risk factors exist before anorexia started, so it is not a case of low BMI simply being a consequence. Instead, being genetically prone to having a low BMI is a risk factor for anorexia nervosa. Even so, the authors controlled for the effects of these BMI SNPs and found that there was still an independent association of anorexia nervosa with genetic variants linked to metabolism.
Systems biology approaches looking at cell types showed higher SNP concentration in the central nervous system. Interestingly, further analysis suggested that the neurons involved include those linked to feeding behaviours, including food motivation and reward. But this is a tentative observation.